CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The T-RAFIC project aims to enhance understanding of how immune cells move and interact after cancer immunotherapy. By utilizing advanced imaging technologies, it seeks to improve the effectiveness of immune-related treatments and foster new therapeutic strategies in oncology.
Cancer immunotherapies have been established in a growing number of clinical indications and the pace of development is massively accelerating.
Currently over 6.000 clinical trials are investigating immune-related treatments in oncology especially in combinations.
It includes both adoptive cellular therapies and immune modulating treatments like immune check point blockade.
In contrast, the understanding of how such therapies mediate their mode of action is still mostly poorly understood.
In pa…
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
TECHNICAL UNIVERSITY OF DENMARK DTU
Denmark, Kongens Lyngby
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Amsterdam
Type: Research institute
Activity type: Research Organisations
SME: No
Denmark, Hillerod
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
